Endogenous Myc maintains the tumor microenvironment. - Wikidata - awgldk - TriplyDB

Endogenous Myc maintains the tumor microenvironment.

Endogenous Myc maintains the tumor microenvironment.

http://www.wikidata.org/entity/Q34177033

about

Small molecule inhibitors of aurora-a induce proteasomal degradation of N-myc in childhood neuroblastoma Small-molecule inhibitors of the Myc oncoprotein MYC activation is a hallmark of cancer initiation and maintenance OmoMYC blunts promoter invasion by oncogenic MYC to inhibit gene expression characteristic of MYC-dependent tumors Therapeutic aspects of c-MYC signaling in inflammatory and cancerous colonic diseases Drugging the addict: non-oncogene addiction as a target for cancer therapy Inhibitor of MYC identified in a Kröhnke pyridine library MYC on the path to cancer Inactivation of MYC reverses tumorigenesis.The action mechanism of the Myc inhibitor termed Omomyc may give clues on how to target Myc for cancer therapy.Exploiting biological diversity and genomic aberrations in chronic lymphocytic leukemia.Myc inhibition is effective against glioma and reveals a role for Myc in proficient mitosis.The Max b-HLH-LZ can transduce into cells and inhibit c-Myc transcriptional activities.Cancer. Taking a back door to target Myc.A cell engineering strategy to enhance the safety of stem cell therapies.Transcriptional amplification in tumor cells with elevated c-Myc.Decorin protein core affects the global gene expression profile of the tumor microenvironment in a triple-negative orthotopic breast carcinoma xenograft model The bromodomain and extra-terminal inhibitor CPI203 enhances the antiproliferative effects of rapamycin on human neuroendocrine tumors.Pten mediates Myc oncogene dependence in a conditional zebrafish model of T cell acute lymphoblastic leukemia.Finding cancer's weakest link.Genomics in 2011: challenges and opportunities.Myc and Omomyc functionally associate with the Protein Arginine Methyltransferase 5 (PRMT5) in glioblastoma cells.Deciphering the Key Features of Malignant Tumor Microenvironment for Anti-cancer Therapy Strategies to Inhibit Myc and Their Clinical Applicability Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma.Inhibition of Myc family proteins eradicates KRas-driven lung cancer in mice Noncanonical roles of the immune system in eliciting oncogene addiction Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma Growth suppression by MYC inhibition in small cell lung cancer cells with TP53 and RB1 inactivation.Multiple Roles of MYC in Integrating Regulatory Networks of Pluripotent Stem Cells.Andrographolide suppress tumor growth by inhibiting TLR4/NF-κB signaling activation in insulinoma Natriuretic peptide receptor A signaling regulates stem cell recruitment and angiogenesis: a model to study linkage between inflammation and tumorigenesis.The chemokine system and cancer.Tumor microenvironment: becoming sick of Myc.Immunology in the clinic review series; focus on cancer: multiple roles for the immune system in oncogene addiction.The impact of tumor microenvironment on cancer treatment and its modulation by direct and indirect antivascular strategies.MYC oncogene in myeloid neoplasias.MYC-y mice: from tumour initiation to therapeutic targeting of endogenous MYC.The fine balance of chemokines during disease: trafficking, inflammation, and homeostasis.The accumulation of DNA repair defects is the molecular origin of carcinogenesis.

P2860

Q24296639-4CFB43F4-94A6-41CA-843F-E5EF7E0159AE Q27025648-736B4419-1F7F-4802-8532-5F6EBD2E1C93 Q27026026-87F6D332-66BA-4E26-90FF-8FFC0D48A401 Q27728475-ED008A81-55C7-46CB-A814-06DD261DFDD0 Q28071309-987AEED1-9D29-4EE5-AD27-865AC7BC0845 Q28079559-8DBA5707-6E44-4EFB-BD7A-15595E9C737B Q28656132-38141B2B-D064-4BEF-B135-B9D14A537181 Q29619979-F9C2080A-C9B2-4844-BDF1-D2C2B9F5C267 Q33784668-168F899A-7B10-4441-A1FF-D13F24FAC629 Q33979793-5302D782-F7C4-4982-949E-494A49C73A95 Q34056568-679F32AC-4BAC-43F8-838B-70E0F0B94544 Q34086373-0092ECD2-DAFA-40AF-92EA-E00A1452DAE4 Q34182321-3BA27E78-9C6C-48E3-B760-60F85263AEFC Q34248946-76BA1FD4-4D2D-4FBD-90B8-33870348AB10 Q34254731-1CC2B9D6-8CC6-4673-857F-4D9A28764763 Q34302542-A5A0D880-049D-4385-9768-A8529FBEE2A9 Q34429416-5AA8A196-4799-42C7-B2DB-7E3BAEF0CE60 Q34541532-2078CE0E-34FF-4689-8402-4CFF6EA6B7BE Q35144582-2FC2BFC3-0169-4253-BEAA-611F76DD3C22 Q35764388-F1C04499-4459-41F7-87BC-A9C15B3C9B4B Q35907654-3A8DF90E-5B79-4326-A527-533109529CE3 Q36275660-E0A2B9D2-1B33-4AF8-915A-897426856F2B Q36284940-EA1FAFF2-5A61-4635-A864-FEAF7FB10954 Q36303678-36FFE599-B170-4115-B1E5-666A0073E2A2 Q36625697-1C348144-5742-4FA7-B433-C377FF74D932 Q36708046-6F5765A4-362D-4FA5-B11C-2E6480A5082A Q36931816-F2A44AC9-A45E-4EF8-976E-B50F19229160 Q37123636-5C6D0ADD-BB1E-4CA7-9E95-22D8EC6A3563 Q37327647-540C84D2-4E21-4237-AB03-D9B21D590CFF Q37622098-097D2E5C-AC8E-4D5A-BE19-833014DCB9B4 Q37692732-AAEAA211-518E-44AA-A50A-DDAD0FB47325 Q37695537-7519FEDA-0B6F-475E-BF6A-5C757DEFA578 Q37944479-73788CE9-D4F9-4975-BBB6-D240B9572C38 Q37950255-6A7FB939-BAB4-4109-BCFE-91A70A00B314 Q37974936-78873E68-D28D-4026-B84C-50EE115F8DF1 Q38028791-768BE24C-3E9C-428C-945E-0EE8521C4ECA Q38036610-C6F27978-78CD-49D0-AB8C-B9DE2C4568CA Q38092448-A32DC8EF-4D3D-4135-BC0A-B6EF168779F8 Q38102623-F59551B3-05F7-4673-B740-34A5A25F69C9 Q38125930-8D6F7CCC-7DFF-4147-9646-2E11DD8EE2D1

P2860

Endogenous Myc maintains the tumor microenvironment.

http://www.wikidata.org/entity/Q34177033

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Endogenous Myc maintains the tumor microenvironment.

@ast

Endogenous Myc maintains the tumor microenvironment.

@en

Endogenous Myc maintains the tumor microenvironment.

@nl

type

label

Endogenous Myc maintains the tumor microenvironment.

@ast

Endogenous Myc maintains the tumor microenvironment.

@en

Endogenous Myc maintains the tumor microenvironment.

@nl

prefLabel

Endogenous Myc maintains the tumor microenvironment.

@ast

Endogenous Myc maintains the tumor microenvironment.

@en

Endogenous Myc maintains the tumor microenvironment.

@nl

P1433

Q34177033-B9FB21FC-3DE9-4209-87DC-9EDFEB08122E

P1476

Q34177033-6449DC59-E437-43C3-BAD3-D6BD4758E888

P2093

Q34177033-1246008A-AE58-4F15-A2EB-CDFB7738A6A3

Q34177033-250880E5-22F4-4318-9DC8-BD595D47ED50

Q34177033-B96B6942-DA97-414B-B2CA-825A8808ED6D

Q34177033-BE15D210-72B6-4BDD-BF4E-52166851E48F

Q34177033-D5FB2F87-D32F-4D74-BC0C-3693A05A2664

P2860

Q34177033-0D2B981C-4F79-4850-9067-23472EFDC6F7

Q34177033-1E60AF1F-EF4F-4EA3-8C08-1269E0FB9F59

Q34177033-2C04AF82-0A02-435B-BE25-B9EDA0C7003C

Q34177033-2D965807-1404-42EC-8FDD-61C3A13D22A9

Q34177033-3717D06C-1BCC-4082-B2F8-616F70AC16E3

Q34177033-3A66500F-FB15-4D15-ACB2-98BCB6519CA1

Q34177033-3D56F535-CC69-4E01-86F8-9ECC3F15D4C6

Q34177033-3F816627-AE67-4C05-B1CD-0A7234365E88

Q34177033-5391494F-73EE-4668-A1A5-97568AEF8F3B

Q34177033-543B8DCE-1AF0-4271-843F-34DEF4B2BC48

P304

Q34177033-737F5DE9-4914-4C62-934C-30BFECF339D0

P31

Q34177033-93DBC245-BD03-4FAB-9EE7-965A1020CC23

P356

Q34177033-59FE31A6-9CA9-4B2B-82FD-568BD790371B

P433

Q34177033-BBDE65EA-D842-4506-9448-FFDDBB114BE8

P478

Q34177033-4275DEB6-0AF5-4AD8-BCC2-5DF365C8A0AE

P50

Q34177033-4217DE60-7288-4258-94FF-D113DF5F8AB0

P577

Q34177033-7D56D3F7-CBD5-4342-9EA4-B58509C64901

P5875

Q34177033-B7EF6AF5-92DD-4EDC-9F07-F1E0185B2B8C

P698

Q34177033-3DD4B560-0B2A-4275-9E24-6413B4612FF1

P932

Q34177033-64E10F09-33E9-45CE-A3DC-4BC3228725F0

P356

P1433

Genes & Development

P1476

Endogenous Myc maintains the tumor microenvironment.

@en

P2093

Anthony N Karnezis

http://www.w3.org/2001/XMLSchema#string

Douglas Hanahan

http://www.w3.org/2001/XMLSchema#string

Gerard I Evan

http://www.w3.org/2001/XMLSchema#string

Lamorna Brown Swigart

http://www.w3.org/2001/XMLSchema#string

Nicole M Sodir

http://www.w3.org/2001/XMLSchema#string

P2860

Modes of resistance to anti-angiogenic therapy

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation

Matrix Metalloproteinase Inhibitors and Cancer--Trials and Tribulations

Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors

Expression profiling of ductal carcinoma in situ by laser capture microdissection and high-density oligonucleotide arrays.

Effects of fixation on RNA extraction and amplification from laser capture microdissected tissue.

Induction of angiogenesis during the transition from hyperplasia to neoplasia.

Modelling Myc inhibition as a cancer therapy.

Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis.

P304

907-916

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1101/GAD.2038411

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-04-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51037300

http://www.w3.org/2001/XMLSchema#string

P698

21478273

http://www.w3.org/2001/XMLSchema#string

P932

3084025

http://www.w3.org/2001/XMLSchema#string